Opinion

Video

Adherence and Time Spent Receiving IV Iron Infusions

Author(s):

Melody Chang, RPh, MBA, BCOP,Andre D. Harvin, PharmD, MS, MBA

Panelists discuss how IV iron formulations requiring fewer infusion visits tend to have better adherence rates, while the ongoing nursing shortage has created additional challenges in scheduling and administering IV iron treatments, leading clinicians to favor products that can achieve iron repletion in fewer sessions.

Video content above is prompted by the following:

  • Adherence to recommended treatment dosing tends to decline as the number of separate recommended infusion visits increases. Could you share your clinical experience on how variations in dosing among different agents influence patient adherence?
  • Has the recent nursing shortage impacted your practice in patients requiring IV iron formulations?
Related Videos
Raj Chovatiya, MD, PhD, MSCI.
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
4 experts are featured in this series.
1 expert is featured in this series.
4 experts are featured in this series.
Galen Shearn-Nance, BS
4 experts are featured in this series.
Related Content
"Overactive bladder" written on sticky note | Image Credit: syahrir - stock.adobe.com
April 15th 2025

Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk

Brooke McCormick
Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer a noninvasive method to identify individuals at increased risk of developing overactive bladder.
managed care cast logo
December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Pharmacy online_evso - adobe.stock.com
April 15th 2025

SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps

Giuliana Grossi
Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
MASLD significantly increases the risk of severe infection, a literature review suggests. | Image credit: SewcreamStudio - stock.adobe.com
April 12th 2025

MASLD Associated With 2-Fold Increase of Serious Bacterial Infection

AJMC Contributor
Data from a meta-analysis of 8 observational studies accounting for more than 26 million people across the globe were evaluated in a new review.
Person holding microplastics | Image Credit: Pcess609 - stock.adobe.com
April 11th 2025

Health Risks of Microplastics Highlighted at Recent Medical Conferences

Brooke McCormick
Experts at leading health care conferences last month called for further research into the health effects of microplastics and prompted immediate action to limit exposure.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo